Complementary to surgical procedures such as robot-assisted radical prostatectomy, laparoscopic radical nephrectomy, and open radical cystectomy, thromboprophylaxis is an established standard of inpatient care. Due to its numerous benefits such as reduced risk of venous thromboembolism and post-operative major bleeding, and better perioperative management of antithrombotic agents, the European School of Urology (ESU) established the e-course EAU Guidelines on Thromboprophylaxis.
The latest recommendations of the new 2018 EAU Guidelines which include developments from recent major studies, are integrated into the content. What is the optimal duration of pharmacological prophylaxis? Guidelines say four weeks. What are the recommendations regarding patients receiving antithrombotic agents perioperatively? Guidelines say discontinue antithrombotic therapy during period around surgery; or delay the surgery of patients with a temporary and significantly high risk of thrombosis until risk decreases. If delay is not possible, maintain antithrombotic therapy or bridge through surgery may be advisable. Participants can expect these and other relevant recommendations from the new e-course.
The ESU e-course is divided into 3 Learning Modules consisting of multiple-choice questions. To choose the best answer per question, participants can navigate to corresponding chapters in the Guidelines.
The first module is an introduction to post-surgery thromboprophylaxis, followed by the second module which focuses on thromboprophylaxis for specific surgical procedures. The final module is centred on the perioperative management of antithrombotic agents in urology.
The e-course is available in English and will take approximately 60 to 90 minutes to finish. Participants are required to answer the 10 questions for the final assessment. A passing grade of 80% and above will guarantee an accreditation of one European CME credit (ECMEC®).
Enhance know-how and accumulate more CME credits with other ESU e-courses with topics ranging from non-muscle-invasive bladder cancer, metastatic prostate cancer and more! Visit ESU e-courses webpage for more information.